ArticleKidney international reports2026
Recalibration of the European Kidney Function Consortium eGFR Equation for the Indian Population.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Performance of estimated glomerular filtration rate equations across ethnic groups in the AIM CKD UK cohort: a multicentre cross-sectional study.The Lancet regional health. Europe · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The new European Kidney Function Consortium (EKFC) eGFR equation uses rescaled serum creatinine (SCr) to an age- and sex-specific normal median value, making it applicable across the entire age spectrum. We evaluated the performance of the recalibrated EKFC Methods: Indian adults (healthy and patients with CKD) were recruited. Plasma iohexol clearance was used to assess measured GFR (mGFR). Indian-specific Q values were derived from healthy individuals, and K from those under the age of 40 years. We evaluated EKFC Results: A total of 1174 participants (615 healthy, 559 CKD), mean age 48 years, with equal sex distribution were recruited. The EKFC Conclusion: Recalibrating EKFC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.